168 related articles for article (PubMed ID: 18357736)
21. Determination of glycyrrhizin and 18 alpha-, 18 beta-glycyrrhetinic acid in rat plasma by high-performance thin-layer chromatography.
Vampa G; Benvenuti S; Rossi T
Farmaco; 1992 May; 47(5 Suppl):825-32. PubMed ID: 1524628
[TBL] [Abstract][Full Text] [Related]
22. Assessment of intestinal absorption of vitexin-2''-o-rhamnoside in hawthorn leaves flavonoids in rat using in situ and in vitro absorption models.
Xu YA; Fan G; Gao S; Hong Z
Drug Dev Ind Pharm; 2008 Feb; 34(2):164-70. PubMed ID: 18302035
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous determination of 18alpha- and 18beta-glycyrrhetic acid in human plasma by LC-ESI-MS and its application to pharmacokinetics.
Zou Q; Wei P; Li J; Ge ZX; Ouyang P
Biomed Chromatogr; 2009 Jan; 23(1):54-62. PubMed ID: 18850581
[TBL] [Abstract][Full Text] [Related]
24. Prediction of human absorption of a trioxane antimalarial drug (CDRI 99/411) using an in-house validated in situ single-pass intestinal perfusion model.
Wahajuddin ; Singh SP; Patel K; Pradhan T; Siddiqui HH; Singh SK
Arzneimittelforschung; 2011; 61(9):532-7. PubMed ID: 22029231
[TBL] [Abstract][Full Text] [Related]
25. Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cycling.
Ploeger BA; Meulenbelt J; DeJongh J
Toxicol Appl Pharmacol; 2000 Feb; 162(3):177-88. PubMed ID: 10652246
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of gastrointestinal absorption of glycyrrhizin in rats.
Wang Z; Kurosaki Y; Nakayama T; Kimura T
Biol Pharm Bull; 1994 Oct; 17(10):1399-403. PubMed ID: 7874064
[TBL] [Abstract][Full Text] [Related]
27. Repetitive administration of Shaoyao-Gancao-tang to rats restores the bioavailability of glycyrrhizin reduced by antibiotic treatment.
He JX; Akao T; Tani T
J Pharm Pharmacol; 2003 Nov; 55(11):1569-75. PubMed ID: 14713369
[TBL] [Abstract][Full Text] [Related]
28. The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests.
Kim JS; Mitchell S; Kijek P; Tsume Y; Hilfinger J; Amidon GL
Mol Pharm; 2006; 3(6):686-94. PubMed ID: 17140256
[TBL] [Abstract][Full Text] [Related]
29. Predicting human intestinal permeability using single-pass intestinal perfusion in rat.
Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Azarmi Y; Islambolchilar Z; Barzegar S; Barzegar-Jalali M
J Pharm Pharm Sci; 2007; 10(3):368-79. PubMed ID: 17727800
[TBL] [Abstract][Full Text] [Related]
30. [Multiple analysis of the difference in intestinal absorption between the main components and the extract of Glycyrrhiza uralensis].
Wu QQ; Chen Y; Xin R; Wang JY; Zhou L; Yuan L; Jia XB
Yao Xue Xue Bao; 2012 May; 47(5):657-63. PubMed ID: 22812013
[TBL] [Abstract][Full Text] [Related]
31. The influence of the sennosides on absorption of glycyrrhetic acid in rats.
Mizuhara Y; Takizawa Y; Ishihara K; Asano T; Kushida H; Morota T; Kase Y; Takeda S; Aburada M; Nomura M; Yokogawa K
Biol Pharm Bull; 2005 Oct; 28(10):1897-902. PubMed ID: 16204942
[TBL] [Abstract][Full Text] [Related]
32. Use of the deconvolution principle in the estimation of absorption and pre-systemic intestinal elimination of drugs.
Pithavala YK; Soria I; Zimmerman CL
Drug Metab Dispos; 1997 Nov; 25(11):1260-5. PubMed ID: 9351902
[TBL] [Abstract][Full Text] [Related]
33. [Immunoenzyme test-system for detection of glycyrrhizic acid].
Fediuk NV; Il'icheva TN; Ol'kin SE; Abdullaev SM; Pokrovskiĭ AG
Eksp Klin Farmakol; 2001; 64(5):66-8. PubMed ID: 11764507
[TBL] [Abstract][Full Text] [Related]
34. [Effect of CYP3A and P-glycoprotein on the absorption of buagafuran in rat intestinal lumen].
Sheng L; Tan W; Hu JP; Chen H; Li Y
Yao Xue Xue Bao; 2010 Jan; 45(1):43-8. PubMed ID: 21351448
[TBL] [Abstract][Full Text] [Related]
35. [Absorption of zedoary oil in rat intestine using in situ single pass perfusion model].
You J; Li QP; Yu YW; Cui FD
Yao Xue Xue Bao; 2004 Oct; 39(10):849-53. PubMed ID: 15700830
[TBL] [Abstract][Full Text] [Related]
36. Preclinical characterization of intestinal absorption and metabolism of promising anti-Alzheimer's dimer bis(7)-tacrine.
Zhang L; Yu H; Li WM; Cheung MC; Pang YP; Gu ZM; Chan K; Wang YT; Zuo Z; Han YF
Int J Pharm; 2008 Jun; 357(1-2):85-94. PubMed ID: 18358649
[TBL] [Abstract][Full Text] [Related]
37. The blood-brain barrier permeability of 18β-glycyrrhetinic acid, a major metabolite of glycyrrhizin in Glycyrrhiza root, a constituent of the traditional Japanese medicine yokukansan.
Tabuchi M; Imamura S; Kawakami Z; Ikarashi Y; Kase Y
Cell Mol Neurobiol; 2012 Oct; 32(7):1139-46. PubMed ID: 22488528
[TBL] [Abstract][Full Text] [Related]
38. Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat.
Dahan A; West BT; Amidon GL
Eur J Pharm Sci; 2009 Feb; 36(2-3):320-9. PubMed ID: 19028572
[TBL] [Abstract][Full Text] [Related]
39. Bioavailability of glycyrrhizin from Shaoyao-Gancao-Tang in laxative-treated rats.
Goto E; He JX; Akao T; Tani T
J Pharm Pharmacol; 2005 Oct; 57(10):1359-63. PubMed ID: 16259766
[TBL] [Abstract][Full Text] [Related]
40. Toxicological assessment of liquorice: biliary excretion in rats.
Cantelli-Forti G; Raggi MA; Bugamelli F; Maffei F; Villari A; Trieff NM
Pharmacol Res; 1997 May; 35(5):463-70. PubMed ID: 9299212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
